- Patent Title: Drug delivery device with integrated optical-based glucose monitor
-
Application No.: US17487570Application Date: 2021-09-28
-
Publication No.: US12128215B2Publication Date: 2024-10-29
- Inventor: Steven Cardinali , David Nazzaro , Ian McLaughlin
- Applicant: Insulet Corporation
- Applicant Address: US MA Acton
- Assignee: INSULET CORPORATION
- Current Assignee: INSULET CORPORATION
- Current Assignee Address: US MA Acton
- Agency: GOODWIN PROCTER LLP
- Main IPC: A61M5/172
- IPC: A61M5/172

Abstract:
Embodiments of the present disclosure relate to approaches for more efficiently measuring glucose levels using a wearable drug delivery device. In some embodiments, the wearable drug delivery device may include a needle deployment component including a cannula and an optical conduit deployable into a user, the cannula operable to deliver a liquid drug to the user. The wearable drug delivery device may further include a glucose monitor including an optical sensor, the optical sensor operable to measure a light output received via the optical conduit.
Public/Granted literature
- US20220096749A1 DRUG DELIVERY DEVICE WITH INTEGRATED OPTICAL-BASED GLUCOSE MONITOR Public/Granted day:2022-03-31
Information query
IPC分类: